Novo CEO pressed by Senate to cut selling prices of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the organization would contemplate new talks with insurers concerning the checklist selling prices of Wegovy and copyright should they pledge to keep the medicines on their own formularies. Will https://kylerxndto.slypage.com/31178645/the-smart-trick-of-healthcare-news-that-nobody-is-discussing